Search results

• Fallout shelter
  ...the Federal Housing Authority, examples being Barrington Plaza, and other development projects of Los Angeles County Civil Defense and Disaster Commissioner, Lou ...sium iodide]] at the rate of 130 mg/day per adult (65 mg/day per child) as an additional measure to protect the human thyroid gland from the uptak
  24 KB (3,899 words) - 19:58, 11 June 2010
• Type 93 torpedo
  {{redirect|Long Lance|the American Indian writer|Chief Buffalo Child Long Lance}} ==History and development==
  17 KB (2,630 words) - 21:40, 2 July 2010
• Erythromycin
  ...thromycin A a formidable task.<ref>Pal, S. A journey across the sequential development of macrolides and ketolides related to erythromycin. Tetrahedron. 2006. 62. ...at risk for developing hypertrophic pyloric stenosis? |journal=Arch. Dis. Child. |volume=92 |issue=3 |pages=271–3 |year=2007 |month=March |pmid=17337692
  19 KB (2,731 words) - 17:52, 18 September 2010
• Flucytosine
  ...ening fungal infections due to relatively weak antifungal effects and fast development of resistance, but rather in combination with amphotericin B and/or [[azole ...osine is distributed in human breast milk. Given the potential risk to the child, the patient should not [[breastfeeding|breastfeed]] during treatment with
  10 KB (1,394 words) - 16:44, 27 September 2010
• Abacavir
  ...or restarting treatment with abacavir or abacavir containing medications. Development of clinically suspected abacavir HSR requires immediate and permanent disco Child (age 3 months - 16 years) 3.6&nbsp;mg per lb. of body weight twice a day, u
  8 KB (1,124 words) - 16:44, 27 September 2010
• Nevirapine
  ...ion]</ref><ref>{{cite journal |author=Conway B, Wainberg MA, Hall D |title=Development of drug resistance in patients receiving combinations of zidovudine, didano The most common adverse effect of nevirapine is the development of mild or moderate rash (13%).<ref name=PInfo/><ref name=ATDN>{{cite web
  15 KB (2,090 words) - 16:45, 27 September 2010
• Ciprofloxacin
  ...he risk of the child suffering from this syndrome as well, even though the child had never been prescribed or taken any of the drugs found within this class ...onsideration to avoid an accumulation that may lead to an overdose and the development of toxicity. Ciprofloxacin is eliminated primarily by renal excretion. Howe
  88 KB (11,930 words) - 16:46, 27 September 2010
• Mercury (element)
  ...hout the 1800s for numerous conditions including constipation, depression, child-bearing and toothaches.<ref>{{cite news|title = Did Mercury in "Little Blue ...isher=National Risk Management Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Cincinnati, Ohio|accessdate=May 1, 2
  69 KB (10,077 words) - 21:35, 20 September 2010
• Zidovudine
  ===Development=== ...ical settings due to a lack of drugs that were effective against them. The development of the first anti-retroviral drugs in the 1950s and 60s led to increasing e
  21 KB (3,049 words) - 16:51, 27 September 2010
• Amoxicillin
  ...ide to symptoms, emergencies, common illnesses, behavior problems, healthy development |edition=2nd |publisher=Bantam Books |location=New York |year=2005 |pages=
  11 KB (1,413 words) - 16:52, 27 September 2010
• Template:Central nervous system navs
  |border=child ...ted structures|g]])/[[Template:Nervous system physiology|phys]]/[[Template:Development of nervous system and integument|devp]]/[[Template:Human cell types derived
  2 KB (246 words) - 21:37, 20 September 2010
• Template:Endocrine navs
  |border=child ...neoplasia|tumr]], [[Template:Symptoms concerning nutrition, metabolism and development|sysi]]/[[Template:Eponymous medical signs for endocrinology, nutrition, and
  1 KB (144 words) - 16:26, 19 September 2010
• Template:Peripheral nervous system navs
  |border=child ...sensory system|s]])/[[Template:Nervous system physiology|phys]]/[[Template:Development of nervous system|devp]]
  1 KB (149 words) - 16:36, 19 September 2010
• Template:Ear navs
  |border=child ...stibular pathways|p]])/[[Template:Eye and ear physiology|phys]]/[[Template:Development of eye and ear|devp]]
  871 bytes (110 words) - 12:11, 19 September 2010
• Template:Heart navs
  |border=child ...mplate:Heart|anat]]/[[Template:Cardiovascular physiology|phys]]/[[Template:Development of circulatory system|devp]]
  1,018 bytes (120 words) - 20:09, 21 September 2010
• Template:Integument navs
  |border=child ...entary system|anat]]/[[Template:Integumentary physiology|phys]]/[[Template:Development of integument|devp]]
  2 KB (209 words) - 14:54, 10 December 2011
• Template:Respiratory system navs
  |border=child ...e:Thoracic cavity|c]])/[[Template:Respiratory physiology|phys]]/[[Template:Development of respiratory system|devp]]
  1 KB (154 words) - 20:55, 21 September 2010
• Template:Vascular navs
  |border=child ...ower extremity|l]])/[[Template:Cardiovascular physiology|phys]]/[[Template:Development of circulatory system|devp]]
  1 KB (195 words) - 14:57, 19 September 2010
• Template:Digestive system navs
  |border=child ...e:Peritoneum|p]])/[[Template:Gastrointestinal physiology|phys]]/[[Template:Development of digestive system|devp]]/[[Template:Human cell types derived primarily fr
  1 KB (173 words) - 12:47, 19 September 2010
• Template:Nutrition navs
  |border=child ...cofactors|nuvi]], [[Template:Symptoms concerning nutrition, metabolism and development|sysi]]/[[Template:Eponymous medical signs for endocrinology, nutrition, and
  900 bytes (102 words) - 16:41, 19 September 2010

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)